MARKET

SLS

SLS

Sellas Life Sciences Group Inc
NASDAQ
14.76
-0.69
-4.47%
After Hours: 14.59 -0.17 -1.15% 16:27 06/30 EDT
OPEN
15.18
PREV CLOSE
15.45
HIGH
15.88
LOW
13.34
VOLUME
21.42M
TURNOVER
--
52 WEEK HIGH
15.88
52 WEEK LOW
1.390
MARKET CAP
2.90B
P/E (TTM)
-63.4566
1D
5D
1M
3M
1Y
5Y
1D
Why Sellas Remains A Strong Sell After Doubling In Price
Seeking Alpha · 2h ago
Sellas Life Sciences falls -8.9%
TipRanks · 6h ago
SELLAS Life Sciences Shares Fall Tuesday: What's Driving The Move?
Benzinga · 7h ago
Top Biotech Gainers: UPC Expands Patent Portfolio, All Eyes On SLS, What's Behind The QDEL Rumor?
NASDAQ · 17h ago
Biotech Is The Rate Cut Trade In Disguise
Seeking Alpha · 23h ago
Sellas Life Sciences Shares Break Out To New 52-Week High: What's Driving The Momentum?
Benzinga · 1d ago
Sellas Life Sciences rises 16.8%
TipRanks · 1d ago
Iridium Communications, FuelCell Energy, Rocket Lab And Other Big Stocks Moving Higher On Monday
Benzinga · 1d ago
More
About SLS
SELLAS Life Sciences Group, Inc. is a late-stage clinical biopharmaceutical company. The Company is focused on the development of therapeutics for a range of cancer indications. The Company's product candidates are galinpepimut-S (GPS), a peptide immunotherapy directed against the Wilms tumor 1 (WT1), antigen, and SLS009, a selective small molecule cyclin-dependent kinase 9 (CDK9) inhibitor. GPS is a cancer immunotherapeutic agent licensed by Memorial Sloan Kettering Cancer Center (MSK), that targets the WT1 protein, which is present in an array of tumor types. GPS has potential as a monotherapy or in combination with other immunotherapeutic agents to address a broad spectrum of hematologic malignancies and solid tumor indications. The Company is developing SLS009, which is licensed by GenFleet Therapeutics (Shanghai), Inc., for all therapeutic and diagnostic uses in the world outside of mainland China, Hong Kong, Macau, and Taiwan.

Webull offers Sellas Life Sciences Group Inc stock information, including NASDAQ: SLS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SLS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SLS stock methods without spending real money on the virtual paper trading platform.